Mizuho Securities Sticks to Its Hold Rating for Acadia Healthcare (ACHC)

In a report issued on October 29, Ann Hynes from Mizuho Securities maintained a Hold rating on Acadia Healthcare (ACHCResearch Report), with a price target of $64.00. The company’s shares closed last Tuesday at $62.41.

According to TipRanks.com, Hynes is a 5-star analyst with an average return of 12.4% and a 66.8% success rate. Hynes covers the Healthcare sector, focusing on stocks such as AmerisourceBergen, Quest Diagnostics, and TCR2 Therapeutics.

Currently, the analyst consensus on Acadia Healthcare is a Moderate Buy with an average price target of $74.36, representing a 17.7% upside. In a report issued on October 29, Stephens also maintained a Hold rating on the stock with a $66.00 price target.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $68.65 and a one-year low of $34.01. Currently, Acadia Healthcare has an average volume of 448.1K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment classified in the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. The U.K. Facilities segment provides inpatient services through facilities, including mental health hospitals, clinics, care homes, schools, colleges, and children’s homes. The company was founded in January 2005 and is headquartered in Franklin, TN.

Read More on ACHC: